CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-21 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2026-01-21 | Huller Kelly EVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2026-01-08 | Kline Kyle Senior Vice President, CFO | Option exercise 10b5-1 | +3,594 | $51.87 | $186K | 3,594 |
| 2026-01-08 | Kline Kyle Senior Vice President, CFO | Sale 10b5-1 | −3,594 | $101.10 | $363K | 0 |
| 2026-01-08 | Kline Kyle Senior Vice President, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −3,594 | 3,906 | ||
| 2026-01-08 | Norwalk Leslie V Director | Sale 10b5-1 | −2,000 | $101.10 | $202K | 10,419 |
| 2025-12-12 | Norwalk Leslie V Director | Sale 10b5-1 | −4,000 | $88.85 | $355K | 12,419 |
| 2025-12-08 | Paul David C Executive Chairman | Option exercise | +34,375 | $25.52 | $877K | 60,417 |
| 2025-12-08 | Paul David C Executive Chairman | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −34,375 | 0 | ||
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −4,896 | 104 | ||
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise 10b5-1 | +3,646 | $53.14 | $194K | 3,646 |
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise 10b5-1 | +5,000 | $56.43 | $282K | 8,646 |
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise 10b5-1 | +5,000 | $64.44 | $322K | 13,646 |
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise 10b5-1 | +4,896 | $63.68 | $312K | 18,542 |
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Sale 10b5-1 | −18,542 | $90.00 | $1.7M | 0 |
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −3,646 | 1,354 | ||
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −5,000 | 10,000 | ||
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −5,000 | 0 | ||
| 2025-12-01 | Kline Kyle Senior Vice President, CFO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −5,000 | 0 | ||
| 2025-11-25 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise 10b5-1 | +7,500 | $25.96 | $195K | 7,500 |
Page 3 of 10 · 200 trades